Benzo(a)pyrene (BaP) is an environmentally prevalent polycyclic aromatic hydrocarbon (PAH) known to produce immunotoxicity in murine and human lymphocytes. Previous studies by our lab have shown that certain BaP metabolites increase intracellular Ca 2+ in human and murine lymphocytes. The mechanism by which these BaP metabolites increase Ca 2+ may involve src kinase activation and mitochondrial oxidative stress. We have implicated a new pathway of Ca 2+ elevation in lymphocytes produced by a novel BaP metabolite, . This ortho quinone is produced from BaP-7,8-dihydrodiol by aldoketoreductase 1C1 (AKR1C) isoforms in human cells. We have previously shown that 7,8-BPQ increases Ca 2+ levels in an in vitro rabbit skeletal muscle sarcoplasmic reticulum (SR) vesicle model via interaction with ryanodine receptors (RyR). In the present study, we found that 7,8-BPQ produced a RyR-dependent rapid increase in intracellular Ca 2+ in the Daudi human B cell line. However, other BP-diones including 1,6-, 3,6-, and 6,12-BPQs failed to produce a rapid increase in Ca 2+ . Instead they produced a late increase in intracellular Ca 2+ , presumably via a redoxcycling-dependent loss of Ca 2+ buffering capacity by mitochondria. Functional RyR were detected in Daudi using a 3 H-ryanodine binding assay. The studies were extended to normal human peripheral blood and murine spleen cells, where it was found that 7,8-BPQ rapidly elevated intracellular Ca 2+ in B cells and T cells in both species. The Ca 2+ -elevating effect of 7,8-BPQ was prevented by pretreatment with a high concentration of ryanodine (500 mM). Collectively, these results demonstrate a novel mechanism of Ca 2+ elevation by an environmentally relevant metabolite of BaP in murine and human lymphocytes.
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Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants known to be carcinogenic and immunotoxic in humans and animals (Burchiel and Luster, 2001 ). The immunotoxicity of PAHs is likely due to a combination of genotoxic and nongenotoxic mechanisms, such as alterations in signaling and oxidative stress pathways. Benzo(a)pyrene (BaP), a prototypic PAH, has been widely investigated for many years. Certain metabolites of BaP, most notably 9, , formed by BaP bioactivation with cytochrome P450 1B1/1A1 (CYP1B1/1A1) and microsomal epoxide hydrolase (EPHX1), appear to be important in immunotoxicity. Our previous studies have shown that BPDE alters cell signaling and Ca 2þ homeostasis in lymphoid and nonlymphoid cells (Burchiel and Luster, 2001; Davila et al., 1995; Mounho et al., 1997; Tannheimer et al., 1997 Tannheimer et al., , 1999 Zhao et al., 1996) . BPDE and other PAHs may act via direct or indirect activation of protein tyrosine kinases that are associated with cell signaling through T-and B-cell antigen receptors (Archuleta et al., 1993; Davila et al., 1999; Mounho and Burchiel, 1998) .
Calcium is an important second messenger that regulates various biological functions in cells (Berridge, 2001) . Calcium signaling in lymphocytes and other cells is influenced by such properties as the duration, intensity, or frequency of oscillations (Lewis, 2003) . We have found that several BaP metabolites alter Ca 2þ signaling in Daudi human B cells, albeit by different mechanisms. Cytochrome P450 activation of BaP appears to be critical for immunotoxicity to human peripheral blood cells (Davila et al., 1996) . Our previous studies also found that BaP-7,8-diol alters intracellular calcium levels after several hours of treatment of normal human peripheral blood mononuclear cells (HPBMC) (Mounho and Burchiel, 1998) . Using Daudi human B cells as an in vitro model, we found increases in Ca 2þ levels through activation of Src-like protein tyrosine kinases (Mounho and Burchiel, 1998) . Recently, we found that quinones of BaP (BPQs) also signal Ca 2þ , but through several different pathways. BP-quinones, including 1,6-BPQ, 3,6-BPQ, and 6,12-BPQ, are formed through cytochrome P450,
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1 To whom correspondence should be addressed at 1 University of New Mexico-MSC09 5360, Albuquerque, NM 87131-0001. Fax: (505) 272-6749. E-mail: sburchiel@salud.unm.edu. peroxidase, and photochemical (UV) reactions (Reed et al., 2003) . BPQs are known to redox-cycle, leading to oxidative stress and energy depletion in mitochondria followed by loss of Ca 2þ buffering capacity in cells (Zhu et al., 1995) . More recently we discovered another potential mechanism of Ca 2þ elevation in cells due to a unique interaction of an ortho-BPQ (7,8-BPQ) with ryanodine receptors (RyR) (Pessah et al., 2001) . In these studies, we found that 7,8-BPQ causes Ca 2þ release in rabbit skeletal muscle sarcoplasmic reticulum (SR) vesicles through a selective interaction with RyR.
RyR are homotetrameric calcium release channels of intracellular stores, which were first described on the sarcoplasmic reticulum (SR) in mammalian skeletal muscle cells and cardiac muscle cells (Fill and Copello, 2002; McPherson and Campbell, 1993) . More recently, RyR have been found on the endoplasmic reticulum of nonexcitable cells (Sei et al., 1999) . Mammalian RyRs are expressed as three widely distributed isoforms: RyR1, RyR2, and RyR3. Recent studies have shown that RyR1 and RyR2 are expressed in nonexcitable cells, such as lymphocytes (Sei et al., 1999) . RyR3 is widely expressed in many types of cells (Ogawa et al., 2000) . To investigate the role of RyR, ryanodine binding, which occurs only with the open channel, is frequently used as a probe of RyR function (Pessah et al., 1986) 
MATERIALS AND METHODS
Reagents and antibodies. Benzo(a)pyrene (BaP, Sigma Cat. No. B1760) (purity >97%) and ryanodine (purity >95%) (Sigma Cat. No. R6017) were obtained from Sigma-Aldrich (Sigma Chemical Co., St. Louis, MO). All BaP metabolites used in this paper were purchased from Midwestern Research Institute (Kansas City, MO), with the exception of 7,8-beno(a)pyrene quinone (7, that was provided by the Penning laboratory. Tissue-culture grade (purity >95%) dimethyl sulfoxide (DMSO) (Sigma Chemical Co., St. Louis, MO) was used to dissolve and dilute BaP and its metabolites, and the final concentration of DMSO used was adjusted to 0.1% (v/v). Fluo-3/AM was purchased from Molecular Probes (Eugene, OR). Fico/Lite LymphoH (Cat. No. 140150) was purchased from Atlanta Biological (Lawrenceville, GA).
Phycoerythrin (PE)-conjugated mouse anti-human CD3 and mouse anti-human CD19 monoclonal antibodies were from BD Pharmingen (San Diego, CA).
Cell line. The Daudi human B cell line was obtained from American Type Culture Collection (Rockville, MD) and was grown in a humidified, 37°C, 5% CO 2 incubator in complete RPMI 1640 medium containing 20% fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin, 100 lg/ml streptomycin (Cambrex), and 2 mM L-glutamine.
Preparation of human peripheral blood mononuclear cells (HPBMC). Human mononuclear cells were isolated from healthy blood donors under an approved IRB protocol using Fico/Lite LymphoH density gradient centrifugation method. Briefly, collected peripheral blood was placed in 6 3 10 ml VacutainerÒ plasma tubes with heparin (VWR Cat. No.VT6480). Heparinized blood was diluted with equal volume of sterile phosphate-buffered saline (PBS) (without calcium and magnesium salts) (Sigma Chemical Co., St. Louis, MO), and then 30 ml of this mixture was overlayed on 15 ml Fico/Lite LymphoH at room temperature (RT). After density gradient centrifugation for 30 min at 200 3 g without brake at RT, peripheral blood mononuclear cells were collected from the white layer between the plasma fraction and the Fico/ Lite LymphoH fraction. The HPBMC were washed twice with PBS, and the cell pellet was then resuspended in 3 ml complete RPMI 1640 medium containing 10% fetal bovine serum (Hyclone, Logan, UT), 100 units/ml penicillin, 100 lg/ml streptomycin (Cambrex), and 2 mM L-glutamine. Cells were counted and adjusted to 20 3 10 6 cells/ml.
Preparation of mouse spleen cells. Spleens from female wild-type C57BL/6N mice (13-14 weeks old) (Harlan laboratories, Indianapolis, IN) were aseptically removed and were dissociated in RPMI 1640 complete medium supplemented with 10% fetal bovine serum, 100 lg/ml streptomycin, 100 unit/ml penicillin, and 2 mM L-glutamine. Cells were centrifuged at 280 3 g for 10 min, and pellets were resuspended and maintained in 2 ml RPMI 1640 complete medium on ice. The nucleated spleen cells were counted using the trypan blue (Sigma Chemical Co., St. Louis, MO) exclusion method.
Intracellular calcium measurement using flow cytometry. The analysis of intracellular Ca 2þ levels in Daudi human B cells, HPBMC, and mouse spleen cells was performed by flow cytometric methods (Burchiel et al., , 2000 Rethi et al., 2002) . For all experiments, cells were loaded with in 200 ll of 2 lM Fluo-3/AM (Molecular Probes) in FACS tubes and incubated at 37°C, 5% CO 2 for 1 h, with cells being resuspended approximately every 20 min to ensure even dye loading. Then 800 ll of Dulbecco's phosphate buffered saline (DPBS) (with calcium and magnesium) were added to yield a 1 ml solution. Ca 2þ responses were observed in two ways: (1) For rapid real-time analysis, Fluo-3 loaded cells were treated with various PAHs and continuously monitored for up to 30 min. (2) For longer incubations periods (1 h or more), after treatment with PAHs, cells were loaded with Fluo-3, and the fluorescence intensity was measured by flow cytometry. For Daudi human B cell experiments, cells were resuspended in complete RPMI medium at 2 3 10 5 cells/ml, and 1-ml cell aliquots were placed into three 12 3 75 mm tubes. After the centrifugation and aspiration, the cells were loaded with Fluo3. For HPBMC studies, 10 ll of 20 3 10 6 cells/ml HPBMC were loaded with Fluo-3 and stained with PE-conjugated mouse anti-human CD3 or mouse anti-human CD19 to label T or B cells, respectively. For murine spleen cell studies, 10 ll of 20 3 10 6 cells/ml murine spleen cells were put in 12 3 75 mm tubes and loaded with the addition of 200 ll of Fluo-3AM. After 1 h, 800 ll of DPBS solution was added to yield 2 3 10 5 cells/ml. Tubes were capped and covered with aluminum foil to transport to Flow Cytometry Facility for analysis. Fluorescence intensities were measured in the resuspended cells by FACSCalibur (Becton Dickinson Immunocytometry Systems, San Jose, CA) to obtain baseline readings. Mean channel fluorescence intensities were calculated using CellQuest software. H-ryanodine (Pessah et al., 1987) . The binding reaction was initiated by the addition of microsomal membranes to the medium, and the mixture was permitted to equilibrate at 37°C for 2 h. Nonspecific binding was assessed in the presence of 10 lM unlabeled ryanodine. Separation of bound and free ligand was performed by rapid filtration through Whatman GF/B glass fiber filters using a Brandel cell harvester (Gaithersburg, MD). Filters were washed with two volumes of 0.5 ml ice-cold wash buffer containing 20 mM Tris-HCl, 250 mM KCl, 15 mM NaCl, 50 lM CaCl 2 , pH 7.1, and placed into vials with 5 ml scintillation cocktail (Ready Safe; Beckman Instruments, Inc., Fullerton, CA). The 3 H-ryanodine remaining on the filters was quantified by liquid scintillation spectrometry.
Measurement of
Statistical design and analysis. All of the data reported in this paper were analyzed by SigmaStat software (SPSS, Point Richmond, CA). The statistical differences were determined by one-way analysis of variance (ANOVA) followed by Bonferroni multiple comparison test, Dunnett's test and Student's t-test. A p-value of 0.05 between DMSO control and PAH-treated samples was considered significant.
RESULTS

Immediate Ca 2þ Response Produced by 7,8-BPQ in Daudi Human B Cells
The immediate calcium responses produced by BaP and various metabolites were evaluated using real-time flow cytometry. As shown in Figure 1A (Fig. 2A) . 7,8-BPQ did not show any Ca 2þ effect at these late time points. These results suggest that increases in intracellular Ca 2þ by BaP metabolites may be associated with different metabolic pathways and mechanisms. BaP itself does not possess significant Ca 2þ -elevating activity at early time points in Daudi human B Cells. After an 18 h exposure to 1 lM PAH treatments, BPDE, 1,6-BPQ, 3,6-BPQ, and 6,12-BPQ significantly increased intracellular Ca 2þ in Daudi cells (Fig. 2B ). We noted that 3,6-BPQ fluorescence (no Fluo-3 loading) in the green channel was significantly higher than DMSO controls, and therefore controls must be run with and without the Ca 2þ dye to correct for the fluorescence produced by the test compound; however, none of the other PAHs demonstrated significant fluorescence at the wavelength pairs used to measure Fluo-3 (not shown). Therefore, only background fluorescence associated with 3,6-BPQ needed to be corrected for analysis with Fluo-3.
FIG. 1. Flow cytometric analysis of the rapid calcium release by BaPquinones in Daudi Human B cells. Daudi human B cells (2 3 10
5 cells) were loaded in 200 ll, 2 lM Fluo-3/AM at 37°C, 5% CO 2 for 1 h; 800 ll complete RPMI medium was then added to yield 2 3 10 5 cells/ml. Fluorescence intensities were measured in real-time using a FACSCalibur. (A) After loading with Fluo-3, Daudi cells were dosed with 1 lM PAHs, and the fluorescence intensities were monitored for 6 continuous min. (B) after the baseline measurement, Daudi cells were treated with 1 lM BaP-7,8-quinone (7,8-BPQ), and measurement of the change of fluorescence intensities continued for 30 min. Mean channel fluorescence intensities were calculated by CellQuest software. The plots represent the mean ± standard error of triplicate measurements. Asterisks (*) indicate statistically significant differences from the DMSO vehicle control ( p < 0.05 by Dunnett's test).
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Detection of RyRs in Daudi Human B Cells
Because ryanodine specifically binds RyR in the open state, high-affinity binding of 3 H-ryanodine can be used to verify the expression of functional RyR (Pessah et al., 1986) . Figure 3 shows the specific binding of 3 H-ryanodine to Daudi microsomal membranes. RyRs are large (~560 kDa) homotetrameric receptors that mediate Ca 2þ release from the endoplasmic reticulum stores. Our previous studies show that 7,8-BPQ induces RyR-mediated Ca 2þ release from microsomal fractions (Pessah et al., 2001) . Thus, this result, coupled with our Ca 2þ studies above, demonstrates that functional RyRs are expressed in human lymphocytes.
The Immediate Calcium Response Induced by 7,8-BPQ Is Inhibited by Ryanodine in Daudi Cells
Previous investigators found that RyRs are expressed in Jurkat T-lymphocytes (Hohenegger et al., 1999) and play an important role in the regulation of intracellular Ca 2þ . To test whether RyRs are responsible for 7,8-BPQ-induced Ca 2þ elevation, we used ryanodine (50 and 100 lM) to specifically block the RyRs. As reported earlier, high concentrations of ryanodine (>100 lM) irreversibly inhibit RyR-mediated Ca 2þ release (Zimanyi et al., 1992) . Daudi human B cells were pretreated with 100 lM ryanodine and loaded with the Fluo-3 dye for 1h. PAH treatments were added after the baseline reading, and samples were monitored for 20 min by flow cytometry (Fig. 4) 
Immediate Calcium Response in HPBMC
To investigate the immediate Ca 2þ response in normal HPBMC, freshly isolated HPBMC from healthy blood donors were treated with 1,6-BPQ, 3,6-BPQ, 7,8-BPQ, or DMSO in vitro. We observed that the 7,8-BPQ increase in intracellular Ca 2þ was maximal at about 10 min, which was a result quite similar to that obtained with Daudi (Fig. 5A) . Unlike Daudi, however, the rise in intracellular Ca 2þ in HPBMC was maintained for much longer periods of times (data not shown). Because HPBMC are composed of both T and B lymphocytes, we wondered whether these cells have the same intracellular Ca 2þ response to 7,8-BPQ. Mouse anti-human CD3 and CD19 monoclonal antibodies were used to study the human T-and B-cell subsets. Results showed that 7,8-BPQ significantly increased intracellular Ca 2þ in both cell populations (Fig. 5B) . Interestingly, the Ca 2þ response to 7,8-BPQ in B cells appeared to be higher than in T cells.
To examine the role of the RyR in the 7,8-BPQ-induced immediate Ca 2þ response, HPBMC were pretreated with 50 lM or 500 lM ryanodine for 1 h. We observed that both concentrations of ryanodine reduced the Ca 2þ response produced by 7,8-BPQ (Fig. 6) . Inhibition of the Ca 2þ response was not complete, however, suggesting that other mechanism may also be involved in the response to 7,8-BPQ.
7,8-BPQ Produces Immediate Ca 2þ Response in Mouse Splenocytes
To further extend our findings in HPBMC to murine lymphocytes, we investigated the response of mouse spleen cells to 7,8-BPQ. As shown in Figure 7A , the immediate Ca 2þ increase was only observed in the 7,8-BPQ-treated group of spleen cells. The mouse spleen cell response (~80 channel fluorescence shift) was somewhat lower than that seen in HPBMC (over 120 channel fluorescence shift). 1,6-BPQ and 3,6-BPQ treatments did not produce significant changes in intracellular Ca 2þ in spleen cells compared with DMSO control. To determine if this Ca 2þ increase was mediated by RyR, we pretreated murine spleen cells with different concentrations of ryanodine (50 lM or 500 lM) for 1 h. At the 500 lM FIG. 6. HPBMC pretreatment with ryanodine to block RyRs. HPBMC were pretreated for 1 h with 50 lM or 500 lM ryanodine (Ry) and loaded with Fluo-3/AM dye at 37°C in a 5% CO 2 incubator. Immediate intracellular Ca 2þ responses were monitored in real time by flow cytometry as described in Methods.
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concentration of ryanodine, we found that Ca 2þ elevation was significantly reduced in mouse spleen cells (Fig. 7B) . These results strongly suggest that murine splenocytes also utilize RyR in response to 7,8-BPQ to cause a rapid Ca 2þ signal.
DISCUSSION
Our laboratory is interested in the mechanisms by which BaP and other environmental polycyclic aromatic hydrocarbons (PAHs) produce immunomodulation and immunotoxicity. It is known that BaP can be metabolized by cytochrome P450 and other enzymes to produce bioactive metabolites (Burchiel and Luster, 2001) . These bioactive metabolites include 1, 3, 6, 7, . In the present study we evaluated BaP and six metabolites for their ability to alter Ca 2þ levels in Daudi human B cells, human peripheral blood mononuclear cells (HPBMC), and murine splenocytes using flow cytometry. 7,8-BPQ is a particularly interesting BaP metabolite that is derived from the metabolism of BaP-7,8-dihydrodiol under the influence of a dihydrodiol dehydrogenase (DD1), recently identified as AKR1C1 (Burczynski et al., 1998 (Burczynski et al., , 1999 . We have previously shown that 7,8-BPQ produces a rapid increase in Ca 2þ by activation of ryanodine receptors (RyR) in a rabbit skeletal muscle SR vesicle model system (Pessah et al., 2001) . Concentrations of 0.1-1 lM 7,8-BPQ were required in our studies to elevate intracellular Ca 2þ , which may be at the high end of environmentally relevant concentrations. However, we have no accurate way to determine the actual in vitro concentration of 7,8-BPQ, and it is well known that this agent extensively binds to proteins and other macromolecules, suggesting that the effective concentration may be far less.
Our previous studies demonstrated that two P450-derived metabolites of BPDE and BaP-7,8-Diol increased tyrosine phosphorylation of Lyn and Syk (Mounho and Burchiel, 1998) . This phosphorylation is known to result in the activation of PLC c1 and PLC c2 leading to cleavage of PIP 2 and release of inositol-1,4,5-trisphosphate (IP 3 ) (Winslow et al., 2003) . IP 3 -sensitive Ca 2þ release receptors are located on the ER in lymphocytes. The current studies also demonstrated the presence of ryanodine receptors on microsomes (ER fraction) obtained from Daudi human B cells. Thus, there are apparently two closely related Ca 2þ channels that control Ca 2þ release from the ER of lymphoid cells, the IP 3 R and RyR (Grafton and Thwaite, 2001) . It has been proposed that IP 3 induces a small amount of Ca 2þ release from ER, which then triggers a Ca 2þ -induced Ca 2þ release (CICR) mechanism (Fill and Copello, 2002) . RyR are also activated by increased cytosolic Ca 2þ (Pessah et al., 2001) . Therefore, RyR may play an important role in lymphocytes to induce or maintain Ca 2þ signaling responses.
The present study demonstrated that 7,8-BPQ produces a rapid increase in intracellular Ca 2þ in Daudi human B cells, human peripheral blood B and T cells, and murine spleen cells. By contrast, the Ca 2þ response of other BaP metabolites, including 1,6-BPQ, 3,6-BPQ, and BPDE, occurred at later time points (2-18 h). Therefore, our data suggest that 7,8-BPQ utilizes different signaling pathways to elicit early Ca 2þ effects. Because we detected the presence of RyRs in Daudi microsomes, and we found that high concentrations of ryanodine prevented the 7,8-BPQ Ca 2þ response in Daudi human B cells, human peripheral blood B and T cells, and murine spleen cells, we believe that RyR are responsible for the Ca 2þ response of lymphoid cells to 7,8-BPQ. In our previous work discussed above with BaP-7,8-Diol, we presumed that BaP-7,8-diol was converted to BPDE to produce its effects on src kinases. However, we now know that Daudi and other human lymphocytes express the AKR1C1, and thus they have the ability to make the 7,8-BPQ. Other BPQs also increase intracellular Ca 2þ , but we believe that these much later effects are caused by redox-cycling and loss of Ca 2þ buffering capacity by mitochondria due to ATP depletion, although this hypothesis was not tested in our current studies (Zhu et al., 1995) . Because we found that 7,8-BPQ induces rapid increases in intracellular Ca 2þ levels in human and murine B and T cells, we are now examining pathways for endogenous 7,8-BPQ formation, as well as the regulation of the human AKR1C1 gene in human cells and its homologue in mice.
In summary, we found that 7,8-BPQ is a potent and specific activator of RyR in the present studies leading to a rapid rise in intracellular Ca 2þ in human and murine B and T cells. We believe that the early and rapid Ca 2þ response produced by 7,8-BPQ may be immunomodulatory and may play a role in the immunotoxicity induced by BaP. BPQs have previously been found to activate murine splenic T cells following in vitro treatment at concentrations of 0.1 and 1 lM (Burchiel et al., 2004) , although human leukocytes are inhibited following in vitro treatment with BPQs. Ca 2þ elevation by 7,8-BPQ may also play a role in immune activation, in that many Ca 2þ -sensitive pathways regulate cell activation, such as adhesion molecular activation, enzymatic activation, exocytosis, migration and response to other ion channels activation (Panyi et al., 2004) . Changes in intracellular Ca 2þ are also likely important in specific gene regulation, perhaps through PKCs (Lewis, 2003) . Pomorski et al. (2004) found that intracellular calcium changes regulate cytokine expression, such as IL-1b, and IL8, and effect the monocytes migration. However, this calciumregulated specific gene expression occurs at relatively late time points. Thus, the early and rapid increase in Ca 2þ produced by 7,8-BPQ suggests that RyR may play an important role in lymphocyte activation and may be a target of environmental agents.
